跳至主要内容
临床试验/IRCT20220119053760N2
IRCT20220119053760N2招募中2 期

A randomized Clinical trial to evaluate efficacy of intranasal Montelukast on the outcome of asthma attack in 2-12years old children

Esfahan University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 12 years(—)
性别
All

入选标准

  • Children 2 to 12 years old
  • Hospitalization due to an acute asthma attack with a pulmonary index score (PIS) between 7 and 11 (moderate attack) or a score greater than 12 (severe attack)

排除标准

  • Simultaneous treatment with systemic corticosteroids or antileukotrienes within 4 weeks before admission
  • Other possible causes for the patient's symptoms such as pneumonia
  • Having a history of chronic lung diseases and anatomical airway problems and congenital heart disease
  • History of taking anticonvulsant and immunosuppressive drugs

研究者

相似试验